Cargando…
Potent Therapeutic Strategies for COVID-19 with Single-Domain Antibody Immunoliposomes Neutralizing SARS-CoV-2 and Lip/cGAMP Enhancing Protective Immunity
The worldwide spread of COVID-19 continues to impact our lives and has led to unprecedented damage to global health and the economy. This highlights the need for an efficient approach to rapidly develop therapeutics and prophylactics against SARS-CoV-2. We modified a single-domain antibody, SARS-CoV...
Autores principales: | Zhou, Yajun, Lu, Xing, Wang, Xiaoqing, Ying, Tianlei, Tan, Xiangshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966208/ https://www.ncbi.nlm.nih.gov/pubmed/36835479 http://dx.doi.org/10.3390/ijms24044068 |
Ejemplares similares
-
Antitumor Activity of cGAMP via Stimulation of cGAS-cGAMP-STING-IRF3 Mediated Innate Immune Response
por: Li, Tiejun, et al.
Publicado: (2016) -
cGAMP the travelling messenger
por: Blest, Henry T. W., et al.
Publicado: (2023) -
The Signaling Pathway That cGAMP Riboswitches Found: Analysis and Application of Riboswitches to Study cGAMP Signaling in Geobacter sulfurreducens
por: Tan, Zhesen, et al.
Publicado: (2022) -
Self-assembled cGAMP-STINGΔTM signaling complex as a bioinspired platform for cGAMP delivery
por: He, Yanpu, et al.
Publicado: (2020) -
Human SLC46A2 Is the Dominant cGAMP Importer in Extracellular
cGAMP-Sensing Macrophages and Monocytes
por: Cordova, Anthony F., et al.
Publicado: (2021)